A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Repeated Intra-Articular Injection of SI-613 in Patients With Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Diclofenac-Eatlhyaluronate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Seikagaku Corporation
- 24 Oct 2017 Status changed from not yet recruiting to recruiting.
- 26 Sep 2017 Planned End Date changed from 1 Jul 2018 to 1 Nov 2018.
- 26 Sep 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Aug 2018.